2025-05-02 22:23:17
Latest Post
Strides strengthens Anti-Inflammatory Portfolio with USFDA Approval for Celecoxib Capsules, 100 mg, 200 mg, and 400 mg
KFin Technologies Introduces New-Gen KYC Solution to Streamline Customer Onboarding
Meson Valves India Ltd receives order worth approx Rs. 12.50 crore
Oriental Rail Infrastructure Ltd receives order worth Rs. 2.46 crore
Punjab Chemicals & Crop Protection Ltd recommends dividend of Rs. 3
Stock Report
Aptech Ltd posts higher consolidated PAT of Rs. 17.76 crores in Q3FY23
Posted On : 2023-02-09 23:21:38( TIMEZONE : IST )
Aptech Limited has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 120.2882 crores during the period ended December 31, 2022 as compared to Rs. 110.3812 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 17.7664 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 13.5528 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 4.28 for the period ended December 31, 2022 as compared to Rs. 3.26 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹120.2882 crs | ₹110.3812 crs |  8.98% |
| Net Profit | ₹17.7664 crs | ₹13.5528 crs | 31.09% |
| EPS | ₹4.28 | ₹3.26 | 31.29% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.120.2882 crores during the period ended December 31, 2022 as compared to Rs.81.5452 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.17.7664 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.12.7531 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.4.28 for the period ended December 31, 2022 as compared to Rs.3.10 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹120.2882 crs | ₹81.5452 crs | 47.51% |
| Net Profit | ₹17.7664 crs | ₹12.7531 crs | 39.31% |
| EPS | ₹4.28 | ₹3.10 | 38.06% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.288.6123 crores during the 9 Months period ended December 31, 2022 as compared to Rs.169.7889 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.34.3323 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.23.8880 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.8.27 for the 9 Months period ended December 31, 2022 as compared to Rs.5.80 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹288.6123 crs | ₹169.7889 crs | 69.98% |
| Net Profit | ₹34.3323 crs | ₹23.8880 crs | 43.72% |
| EPS | ₹8.27 | ₹5.80 | 42.59% |
Shares of Aptech Limited was last trading in BSE at Rs. 367.75 as compared to the previous close of Rs. 368.45. The total number of shares traded during the day was 20023 in over 1084 trades.
The stock hit an intraday high of Rs. 377.90 and intraday low of 364.45. The net turnover during the day was Rs. 7410512.00.
